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Accepted 27 August 2012AbstractObjective: To present prenatal diagnosis and molecular cytogenetic characterization of a de novo interstitial duplication of 14q
(14q31.3/q32.12) in a pregnancy associated with abnormal maternal serum biochemistry.
Case Report: A 19-year-old woman underwent amniocentesis in the second trimester because of abnormal maternal serum biochemistry. Her
husband was 33 years old. At 16 weeks of gestation, the levels of a-fetoprotein, unconjugated estriol, total b-human chorionic gonadotropin, and
inhibin Awere 0.8 multiples of median (MoM), 0.84 MoM, 3.06 MoM, and 1.14 MoM, respectively, consistent with a positive trisomy 21 risk of
1/269. Results of an amniocentesis revealed a small de novo interstitial duplication of 14q encompassing 14q31-q32.1. An array comparative
genomic hybridization analysis detected a 6.6-Mb duplication at chromosome 14q31.3-q32.12. Results of a fluorescence in situ hybridization
analysis showed a direct duplication of interstitial 14q. The karyotype was 46,XY,dup(14) (q31.3q32.12). Level II ultrasound was unremarkable.
The parents decided to continue the pregnancy. A 3805-g healthy male baby was delivered at 39 weeks of gestation. When examined at 6 months
of age, the neonate was normal in growth and psychomotor development with no apparent phenotypic abnormalities, although long-term follow-
ups are required.
Conclusion: Abnormal maternal serum biochemistry in the second trimester may be a distinctive prenatal feature in pregnancy associated with
fetal chromosome 14q duplication.
Copyright  2013, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
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Partial trisomy 14q with a duplication of 14q (14q22/q32)
has been associated with a distinct 14q duplication syndrome
characterized by craciofacial dysmorphisms of high forehead,
wide sutures and fontanels, sparse hair and eyebrows, broad
nasal bridge, hypertelorism, thin upper lip, abnormal ears, broad
mouth and micrognathia, developmental delay, mild mental
retardation, spasticity, hyperreflexia, premature puberty, and
primordial short stature [1e5].
Cases of partial trisomy 14q with a duplication of
14q31/qter are rare and present only minor anomalies of an
asymmetric face, frontal bossing, low-set and dysplastic ears,
hypertelorism, sparse eyebrows and lashes, prominent nasal
bridge, small mandible, growth retardation, and moderate
mental retardation [6e13]. Herein, we present prenatal diag-
nosis and molecular cytogenetic characterization of a de novo
interstitial duplication of 14q (14q31.3/q32.12) in a preg-
nancy associated with abnormal maternal serum biochemistry
but without apparent phenotypic abnormalities. To our
knowledge, such a case has not previously been described.
Case report
A 19-year-old, gravida 2, para 1, woman underwent second-
trimester screening for chromosome abnormalities using
maternal serum biochemistry at 16 weeks of gestation. Her
husband was 33 years old. The levels of a-fetoprotein (AFP),
unconjugated estriol (uE3), total b-human chorionic gonado-
trophin (b-hCG), and inhibin-A were 0.8 multiples of median
(MoM), 0.84 MoM, 3.06 MoM, and 1.14 MoM, respectively,
consistent with a positive trisomy 21 risk of 1/269. At 18 weeks
of gestation, she underwent amniocentesis, which revealed
a small interstitial duplicationof 14q encompassing14q31-q32.1
(Fig. 1). Prenatal ultrasound findings were unremarkable. A
repeated amniocentesis was performed at 20 weeks of gestation.Fig. 1. A karyotype of 46,XOligonucleotide-based array comparative genomic hybridiza-
tion usingCytoChipOligoArray (BlueGnome, Cambridge, UK)
on uncultured amniocytes detected a 6.6-Mb duplication at
chromosome 14q31.3-q32.12, or arr cgh 14q31.3q32.12
(84,238,307e90,839,109)  3 (UCSC hg18, NCBI build 36,
March 2006) (Fig. 2). The parental karyotypes were normal. For
fluorescence in situ hybridization (FISH) determination of the
orientation of the duplication of the chromosome 14 [dup(14)],
the bacterial artificial chromosome (BAC) clone probesmapping
the genomic region of 14q31.3-q32.1 were used. The BAC clone
probes RP11-35P13 (85,596,133e85,731,472) (UCSC hg18,
NCBI build 36) (green spectrum) at 14q31.3 and RP11-99C24
(89,927,464e90,094,722) (red spectrum) at 14q32.11 were
used to determine the orientation of the duplication. A FISH
analysis showed an orientation of greeneredegreenered
(Fig. 3), consistent with a direct duplication of interstitial 14q.
Conventional cytogenetic analysis of cultured amniocytes
revealed a karyotype of 46,XY,dup(14)(q31.3q32.12) (Fig. 1).
Level II ultrasound was unremarkable. The parents opted to
continue the pregnancy. At 39weeks of gestation, a healthymale
baby was delivered with a body weight of 3805 g (85th centile),
a body length of 51 cm (85th centile), and a head circumference
of 36 cm (85th centile). There was no dysmorphism. Ultrasound
examinations of internal organs showed normal findings. When
examined at 6 months of age, he was normal in growth and
psychomotor development with no apparent phenotypic abnor-
malities, although long-term follow-ups are required.
Discussion
Abnormal maternal serum biochemistry tests in the first or
second trimester may result in incidental detection of rare fetal
chromosomal abnormalities [14e16]. The present pregnant
woman was 19 years old. She underwent amniocentesis
because of a positive screen risk of 1/269 for trisomy 21
calculated by relatively low levels of AFP and uE3, and anY,dup(14)(q31.3q32.12).
Fig. 2. Oligonucleotide-based array comparative genomic hybridization on uncultured amniocytes shows a 6.6-Mb duplication at 14q31.3-q32.12 (arrow).
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fetuses with an interstitial duplication of 14q may present
abnormal maternal serum biochemistry in the second trimes-
ter, and suggests that abnormal maternal serum biochemistry
may be a distinctive prenatal feature in pregnancy associated
with fetal chromosome 14q duplication.
Our case is the first report of a de novo tandem duplication
encompassing the chromosomal bands from 14q31.3 to
14q32.12 without involving 14q32.2. The present case did not
have the phenotype of uniparental disomy (UPD) 14 and 14q
duplication syndrome. Maternal UPD 14 manifests a pheno-
type of short stature, growth retardation, muscular hypotonia,joint laxity, truncal obesity, small hands, hyperextensible
joints, scoliosis, and mild dysmorphic features of the face,
whereas paternal UPD 14 manifests intrauterine growth re-
striction, polyhydramnios, severe psychomotor retardation,
mild contractures of the fingers, cardiomyopathy, and the
“coat-hanger sign” of the thoracic ribs [17,18]. Genomic
imprinting effects have been observed in chromosome 14
because the 14q32.2 region in human chromosome harbors
paternally expressed genes such as DLK1 and RTL1,
maternally expressed genes such as MEG3 (also known as
GTL2), RTL1as (RTL1 antisense), and MEG8, and the differ-
entially methylated region (DMR) of intergenic DMR and
Fig. 3. Fluorescence in situ hybridization using bacterial artificial chromosome
clone probes RP11-35P13 (85,596,133e85,731,472) (green spectrum) at
14q31.3 and RP11-99C24 (89,927,464e90,094,722) (red spectrum) at
14q32.11. A direct duplication of 14q in the orientation of
greeneredegreenered is evident in the dup(14). The inset shows the amplified
dup(14) and chromosome 14. dup(14) ¼ the chromosome 14 with
a duplication.
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the imprinting genes. However, our case did involve the
duplication of other genes such as FLRT2, GALC, GPR65,
KCNK10, SPATA7, PTPN21, ZC3H14, EML5, TTC8, FOXN3,
C14orf143, TDP1, KCNK13, PSMC1, C14orf102, CALM1,
TTC7B, RPS6KA5, C14orf159, SNORA11B, GPR68, and
CCDC88C. The gene dosage increase effect of those genes is
unknown at the present time. Although this reported neonate
was normal in growth and psychomotor development with no
apparent phenotypic abnormalities, long-term follow-ups are
required for delineating the genotypeephenotype correlation
of dup(14)(q31.3/q32.12).Acknowledgments
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